Inhibition of angiotensin-coverting enzyme by analogs of peptides from Bothrops jararaca venom.

Suppr

超能文献

作者信息

Cushman D W, Pluscec J, Williams N J, Weaver E R, Sabo E F, Kocy O, Cheung H S, Ondetti M A

出版信息

Experientia. 1973 Aug 15;29(8):1032-5. doi: 10.1007/BF01930447.

DOI:10.1007/BF01930447

PMID:4354751

Abstract

摘要

相似文献

Inhibition of angiotensin-coverting enzyme by analogs of peptides from Bothrops jararaca venom.

Experientia. 1973 Aug 15;29(8):1032-5. doi: 10.1007/BF01930447.

Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom.从矛头蝮蛇毒中分离缓激肽增强肽。

Biochemistry. 1970 Jun 23;9(13):2583-93. doi: 10.1021/bi00815a005.

Inhibition of homogeneous angiotensin-converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jararaca.巴西矛头蝮合成毒液肽对兔肺中同源血管紧张素转换酶的抑制作用。

Biochim Biophys Acta. 1973 Feb 15;293(2):451-63. doi: 10.1016/0005-2744(73)90352-5.

Inhibition of angiotensin I converting enzyme by venom peptides.毒液肽对血管紧张素I转换酶的抑制作用。

Br J Pharmacol. 1971 Sep;43(1):252-4. doi: 10.1111/j.1476-5381.1971.tb07176.x.

Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis.从巴西矛头蝮蛇毒液中提取的血管紧张素转换酶抑制剂。分离、结构解析及合成。

Biochemistry. 1971 Oct 26;10(22):4033-9. doi: 10.1021/bi00798a004.

Membrane-active polypeptides from snake venom: cardiotoxins and haemocytotoxins.蛇毒中的膜活性多肽：心脏毒素和血细胞毒素。

Experientia. 1974 Feb 15;30(2):121-9. doi: 10.1007/BF01927688.

Optical rotatory dispersion of proline-rich peptides from the venom of Bothrops jararaca.巴西矛头蝮蛇毒中富含脯氨酸的肽的旋光色散

Experientia. 1971;27(11):1269-70. doi: 10.1007/BF02136679.

Inhibition of the conversion of angiotensin I to II and potentiation of bradykinin by small peptides present in Bothrops jararaca venom.

Circ Res. 1972 Sep;31(9):Suppl 2:62-71.

In vitro study on the effects of bradykinin potentiating factor and angiotensin II analogue on degradation and conversion of angiotensin I and II in plasma.缓激肽增强因子和血管紧张素II类似物对血浆中血管紧张素I和II降解及转化影响的体外研究

Clin Chim Acta. 1974 May 17;52(3):287-92. doi: 10.1016/0009-8981(74)90112-0.

Inhibitors of the pulmonary angiotensin I-converting enzyme.

Biochim Biophys Acta. 1972 Dec 7;289(2):392-400. doi: 10.1016/0005-2744(72)90091-5.

引用本文的文献

A Proline-Based Tectons and Supramolecular Synthons for Drug Design 2.0: A Case Study of ACEI.用于药物设计2.0的基于脯氨酸的构造单元和超分子合成子：以血管紧张素转换酶抑制剂为例

Pharmaceuticals (Basel). 2020 Oct 24;13(11):338. doi: 10.3390/ph13110338.

Hypothesized and found mechanisms for potentiation of bradykinin actions.缓激肽作用增强的假设机制与发现机制。

Signal Transduct. 2006 Feb;6(1):5-18. doi: 10.1002/sita.200500061. Epub 2006 Jan 17.

Considerations for Docking of Selective Angiotensin-Converting Enzyme Inhibitors.选择性血管紧张素转换酶抑制剂的对接考虑因素。

Molecules. 2020 Jan 11;25(2):295. doi: 10.3390/molecules25020295.

Improving Health-Promoting Effects of Food-Derived Bioactive Peptides through Rational Design and Oral Delivery Strategies.通过合理设计和口服递送策略提高食物源生物活性肽的促进健康效果。

Nutrients. 2019 Oct 22;11(10):2545. doi: 10.3390/nu11102545.

Mega clinical trials which have shaped the RAS intervention clinical practice.塑造了RAS干预临床实践的大型临床试验。

Ther Adv Cardiovasc Dis. 2016 Jun;10(3):133-50. doi: 10.1177/1753944716644131.

Drug discovery in renin-angiotensin system intervention: past and future.肾素-血管紧张素系统干预中的药物研发：过去与未来

Ther Adv Cardiovasc Dis. 2016 Jun;10(3):118-25. doi: 10.1177/1753944716642680. Epub 2016 Apr 27.

Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides.天然抑制肽对人血管紧张素转化酶（ACE）活性的分子识别与调控。

Sci Rep. 2012;2:717. doi: 10.1038/srep00717. Epub 2012 Oct 9.

Potentiation of bradykinin actions by analogues of the bradykinin potentiating nonapeptide BPP9alpha.缓激肽增强九肽BPP9α类似物对缓激肽作用的增强作用。

Peptides. 2005 Jul;26(7):1235-47. doi: 10.1016/j.peptides.2005.03.046. Epub 2005 Apr 25.

Phosphorus-containing inhibitors of angiotensin-converting enzyme.含磷的血管紧张素转换酶抑制剂。

Proc Natl Acad Sci U S A. 1982 Apr;79(7):2176-80. doi: 10.1073/pnas.79.7.2176.

Angiotensin-converting enzyme: I. New strategies for assay.血管紧张素转换酶：I. 检测的新策略。

Environ Health Perspect. 1980 Apr;35:165-70. doi: 10.1289/ehp.8035165.

本文引用的文献

The preparation and function of the hypertensin-converting enzyme.血管紧张素转换酶的制备与功能。

J Exp Med. 1956 Mar 1;103(3):295-9. doi: 10.1084/jem.103.3.295.

The existence of two forms of hypertensin.高血压素两种形式的存在。

J Exp Med. 1954 Mar;99(3):275-82. doi: 10.1084/jem.99.3.275.

Bradykinin-potentiating peptides from the venom of Agkistrodon halys blomhoffii.

Experientia. 1969;25(7):694-5. doi: 10.1007/BF01897565.

Structure of bradykinin-potentiating peptide containing tryptophan from the venom of Agkistrodon halys blomhoffii.

Experientia. 1970 Nov 15;26(11):1205-6. doi: 10.1007/BF01897966.

IUPAC-IUB commission on biochemical nomenclature. Symbols for amino-acid derivatives and peptides. Recommendations (1971).国际纯粹与应用化学联合会-国际生物化学联合会生物化学命名委员会。氨基酸衍生物和肽的符号。建议（1971年）。

Biochem J. 1972 Feb;126(4):773-80. doi: 10.1042/bj1260773.

Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung.兔肺血管紧张素转换酶的分光光度测定及性质

Biochem Pharmacol. 1971 Jul;20(7):1637-48. doi: 10.1016/0006-2952(71)90292-9.

Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro. An inhibitor of the pulmonary inactivation of bradykinin and conversion of angiotensin I to II.缓激肽增强肽PCA-Lys-Trp-Ala-Pro。一种缓激肽肺失活及血管紧张素I向II转化的抑制剂。

Biochem Pharmacol. 1971 Jul;20(7):1557-67. doi: 10.1016/0006-2952(71)90284-x.

Biochim Biophys Acta. 1973 Feb 15;293(2):451-63. doi: 10.1016/0005-2744(73)90352-5.

Distribution and properties of angiotensin converting enzyme of rat brain.

J Neurochem. 1972 Oct;19(10):2443-50. doi: 10.1111/j.1471-4159.1972.tb01298.x.

Inhibition of the conversion of angiotensin I to II and potentiation of bradykinin by small peptides present in Bothrops jararaca venom.

Circ Res. 1972 Sep;31(9):Suppl 2:62-71.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验